Eliquis 5 MG tablet 60S
Ended Awarded Last action
- Contract number
- SPE2DR26FXRH7
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $12,416
Award facts
- Contract value 100% obligated
- $12,416.03 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded AmerisourceBergen Drug Corp a delivery order valued at $12,416.03 for 60 tablets of Eliquis 5 mg on December 19, 2025, with an ultimate completion date of December 22, 2025. This firm fixed-price contract represents a competitively awarded, non-set-aside procurement issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.99 billion pharmaceutical supply vehicle running through December 2026. The pharmaceutical distributor, headquartered in Conshohocken, Pennsylvania, serves as a critical vendor for federal medical procurement across the Defense Health Agency, U.S. military healthcare systems, and other federal health programs.
AmerisourceBergen's extensive federal contract portfolio demonstrates significant capability in delivering pharmaceutical products and medical supplies across multiple therapeutic domains to support military and veteran healthcare needs. The DLA Troop Support Medical contract vehicle enables the company to supply brand-name and generic medications, vaccines, and specialized medical commodities globally to federal healthcare systems. This specific delivery order for Eliquis, an anticoagulant medication, exemplifies the routine pharmaceutical replenishment orders executed under the larger IDC framework that AmerisourceBergen manages as a primary pharmaceutical prime vendor for the Department of Defense medical supply chain.
Quick answers
Who was awarded contract SPE2DR26FXRH7?
SPE2DR26FXRH7 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on December 19, 2025.
How much is contract SPE2DR26FXRH7 worth?
The government has obligated $12,416 on SPE2DR26FXRH7.
Is contract SPE2DR26FXRH7 an order under another contract?
Yes. SPE2DR26FXRH7 is a delivery order under SPE2DR25D3004, an indefinite delivery contract.
Was contract SPE2DR26FXRH7 competed?
The extent of competition for SPE2DR26FXRH7 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award